Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Agios Pharmaceuticals Q1 EPS $(1.55) Beats $(1.80) Estimate, Sales $8.73M Miss $9.64M Estimate

Author: Benzinga Newsdesk | May 01, 2025 06:34am
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.55) per share which beat the analyst consensus estimate of $(1.80) by 13.89 percent. This is a 6.9 percent decrease over losses of $(1.45) per share from the same period last year. The company reported quarterly sales of $8.73 million which missed the analyst consensus estimate of $9.64 million by 9.48 percent. This is a 6.56 percent increase over sales of $8.19 million the same period last year.

Posted In: AGIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist